Enhancing dendritic cell vaccine potency by combining a <i>BAK/BAX</i> siRNA‐mediated antiapoptotic strategy to prolong dendritic cell life with an intracellular strategy to target antigen to lysosomal compartments
Tae Heung Kang(Korea University), Tae Woo Kim(Korea University)
Cited by 39
Related Papers
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
|Nature Communications|2020|98
TRPV1 inhibition sensitizes tumors to PD-1 blockade by reversing resistance to CTL-mediated killing
|Scientific Reports|2025|2
CRY1 fuels resistance to T cell-based immunotherapy in NANOGhigh cancers
|Research Square|2025|1